MISSION-CJ for Dual Diagnosis

(STAR-R Trial)

This trial tests a support program for individuals with both substance use and mental health disorders who are released from jail. The study compares two approaches: a full program with structured treatment (MISSION-CJ) and support that links participants to community services (Peer Linkage Support). Researchers aim to determine which method more effectively aids sobriety and mental health improvement. Individuals released from a participating jail with both a substance use and mental health disorder may be suitable for this trial. As an unphased trial, this study provides a unique opportunity to enhance understanding of effective support methods for individuals in similar situations.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Research has shown that the MISSION-CJ program is safe for participants. One study found that it reduced alcohol and drug use, lowered anxiety, and decreased the number of nights participants spent in jail. Participants did not report any major negative effects, indicating the program is generally well-received and helpful for individuals with both substance use and mental health issues.

Peer Linkage Support connects participants to community services. Although specific safety data for this program might not be detailed, peer support models are generally recognized as safe and supportive in mental health and substance use situations.

Researchers are excited about MISSION-CJ and Peer Linkage Support because they offer a fresh approach to treating individuals with dual diagnosis, which involves both mental health and substance use disorders. Unlike standard treatments that often focus separately on mental health or substance use, MISSION-CJ integrates both into a cohesive 6-month program. This comprehensive care includes a structured curriculum directed by a Case Manager and a Peer Support Specialist, which is not commonly found in current treatment plans. Meanwhile, Peer Linkage Support focuses on providing community-based connections and informal treatment planning through a Peer Specialist, offering a supportive yet distinct alternative to more integrated treatments. Both approaches emphasize community linkages and peer support, setting them apart from traditional methods that may not fully address the dual nature of these diagnoses.

Research has shown that the MISSION-CJ program, which participants in this trial may receive, can assist individuals with both mental health issues and substance use problems. Studies have found that participants often use fewer illegal drugs, experience fewer trauma symptoms, and spend less time in jail. The MISSION approach is also associated with improved mental health and more stable housing. In special court settings, past participants demonstrated good treatment results, suggesting that MISSION-CJ could be a helpful option for people facing these dual challenges. Meanwhile, the Peer Linkage Support arm, another treatment option in this trial, focuses on providing linkage care and support to community services, serving as a comparison group to the MISSION-CJ arm.⁶⁷⁸⁹¹⁰